U.S. 10-Year Treasury Yield Hits 2007 High as Fed Rate Hike Bets Rise 
Gold Prices Rise as Oil Slump Eases Fed Rate Hike Fears 
Paramount Skydance Faces $30 Million Film Penalty in Warner Bros. Deal 
South Korea, US Discuss Warship Building Cooperation 
China Reviews Broadcom Switch Use in State Data Centres 
US 10-Year Treasury Yield at 6% Emerges as New Market Risk Threshold 
Oil Prices Rise as U.S.-Iran Talks Fuel Diplomacy Hopes 
Gold Drops Over 1% as Dollar, Treasury Yields Surge on Fed Rate Hike Bets 
Microsoft Stock Upgraded as Stifel Sees Stronger Azure Growth 
Meta Unveils Muse Charm AI Device, Expands Smart Glasses Lineup 
Dollar Hits Two-Month High as Fed Rate Hike Bets Rise 
Oil Prices Extend Losses as U.S.-Iran Talks Ease Supply Fears 
Russian Envoy Dmitriev Heads to US for Ukraine Talks 
RBI Uses $10 Billion Currency Swaps to Drain Excess Rupee Liquidity 
Gold Prices Fall as Treasury Yields Rise on Fed Rate Hike Bets 
H&M Q3 Profit Beats Estimates as Margins Improve 
Add as a preferred source on Google
Reckitt Benckiser announced last weekend that it is selling its Mead Johnson Nutrition company in China to Primavera Capital Group. The deal was said to be valued at $2.2 billion.
As per Reuters, while Primavera Capital has already bought Reckitt Benckiser’s infant formula and child nutrition business in China, the latter will still retain an eight percent stake in the China unit of Mead Johnson Nutrition.
Reckitt to incur a loss on the sale
Reckitt Benckiser is expecting to receive around $1.3 billion from the sale, but it is also anticipating a net loss of $3.5 billion on the disposal. The loss is said to be due to intangible assets and re-measurement of goodwill.
In any case, it was in March when it was first reported that Reckitt Benckiser was considering the sale of the Chinese unit of Mead Johnson. The company observed a sluggish sale and launched a strategic review of its infant formula and child nutrition business in China.
In the end, the sale was decided as sales are not going up anywhere, and Reckitt cited the intense competition with local baby formula brands as one of the reasons for the slow income. Also, the low birth rates in China was also blamed for the dwindling sales as there are fewer babies to feed with the infant formula.
The deal between Reckitt and Primavera
As the sale was revealed, Reckitt Beckinser shared that the deal with Primavera Capital includes the sale of the company’s production factories in Guangzhou, China, and at Nijmegen in the Netherlands. Moreover, a royalty-free perpetual and exclusive license of Mead Johnson and Enfa brands in China, including Enfagrow, Enfamil, and Enfinitas, are also included in the agreement.
Then again, it should be noted that this is only in Greater China, as Reckitt still owns and will continue to sell Mead Johnson and Enfa products in other parts of the world.
"We are pleased to acquire the Greater China business of Mead Johnson, a long-established and renowned multinational infant and children nutrition brand,” Primavera Capital Group founder and chairman, Dr. Fred Hu, said in a press release. “As the controlling shareholder, Primavera is committed to serve tens of millions of Chinese mothers and babies and safeguard their well-being.”
Finally, the Reckitt Beckinser and Primavera Capital deal is expected to close within the second half of this year.
